Search

everythinglearnresearchcommunity

for

Search:↓

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

PRP injections help hair regrowth safely but may need more research.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Finasteride affects prostate weights and pituitary activity differently with age.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.